China's position and competitiveness in the global antibiotic value chain: implications for global health.

ABSTRACT:

Background

Antibiotics are a key commodity for global health, and inadequate access is a major contributor to global mortality. COVID-19 has refocused attention on global pharmaceutical value chains and the need for sustainable and secure production and supply of key products, including antibiotics. Production of antibiotics and their active pharmaceutical ingredients is capital- and technology-intensive, however, and value chains are dominated by a limited number of countries. China is known to be one of the largest producers, but its position in global value chains has not previously been analyzed. This is important for discussions about equitable and resilient global supplies, including through global instruments such as the pandemic treaty.

Methods

This study utilizes da

SUBMITTER: Yang Y 

PROVIDER: S-EPMC11656612 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature